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Caged versions of the most common mitochondrial uncouplers (proton translocators) have been pre-
pared that sense the reactive oxygen species (ROS) hydrogen peroxide to release the uncouplers 2,4-
dinitrophenol (DNP) and carbonylcyanide p-triﬂuoromethoxyphenylhydrazone (FCCP) from caged states
with second order rate constants of 10 (0.8) M1 s1 and 64.8 (0.6) M1 s1, respectively. The trigger
mechanism involves conversion of an arylboronate into a phenol followed by fragmentation. Hydrogen
peroxide-activated uncouplers may be useful for studying the biological process of ageing.
 2010 Elsevier Ltd. Open access under CC BY license. 1. Introduction
Across the world, life expectancy is steadily increasing while the
birth rate is dropping, leading to an ageing population.1 Since age is
the primary risk factor for many diseases,2 understanding the
mechanisms of ageing may allow us to reduce signiﬁcantly
the burden of disease and increase human healthspan. Arguably the
most convincing theory of ageing is the mitochondrial free radical
theory,3 which postulates that the generation of reactive oxygen
species (ROS) in mitochondria is an inevitable consequence of ox-
idative ATP production, and that the ROS are the primary cause of
the macromolecular damage that accumulates to limit lifespan.
However, it is agreed that the theory’s explanation of ageing is
incomplete.4 For these reasons, ﬂuorescent probes have been de-
veloped for detecting ROS,5 and potential therapeutic antioxidants,
particularly those which target the mitochondrion,6,7 are of in-
creasing interest.
Herewe introduce the new concept of functional molecules that
are designed to sense ROS and respond by shutting down the).
Y license. biological processes leading to their production, rather than inter-
acting directly with the ROS like conventional antioxidants. Im-
portantly, the functional molecules wouldmoderate such processes
only when they were leading to the production of excess ROS that
could not be effectively managed by the endogenous antioxidant
system. Their selective and responsive nature should make them
useful chemical biological tools for understanding the effects of
ROS-generating processes on cellular damage and on lifespan. The
advantage of using chemical biology, rather thanmolecular biology,
would be that the functional molecules could be used in any cell
line or organism in a dose-dependent and reversible way. Here we
demonstrate the chemical reactivity of the ﬁrst prototypes.
The electron transport chain in the mitochondrial inner mem-
brane pumps protons out of the mitochondrial matrix to generate
an electrochemical gradient of protons. Protons ﬂowing back
through ATP synthase, then convert the energy of the proton mo-
tive force into chemical energy in the form of ATP. There is evidence
that when the potential across this membrane rises there is a sub-
stantial increase in ROS and many more evade capture by the de-
fence system.8,9 Production of excess ROS involves generation of
superoxide on the inside of the mitochondrial inner membrane by
electron-leakage from complex I and complex III of the electron
transport chain.8,10 Superoxide dismutase (SOD) rapidly converts
C. Quin et al. / Tetrahedron 66 (2010) 2384–2389 2385this superoxide into hydrogen peroxide, which is uncharged at
physiological pH and diffuses away from the matrix of the mito-
chondrion. In the event of the hydrogen peroxide coming into
contact with iron(II) ions, hydroxyl radicals are produced that react
with biomolecules at rates close to that of diffusion causing dam-
age. Our prototype functional molecules are designed to sense
hydrogen peroxide and respond by releasing a proton-translocator
(uncoupler) that will allow protons to ﬂow back across the mito-
chondrial inner membrane without passing through ATP synthase
(uncoupling the electron transport chain from ATP production),11
so reducing the membrane potential and stopping ROS pro-
duction (Scheme 1). Here there is an interesting parallel with
uncoupling proteins, UCP2 and UCP3, which are postulated to cause
mild uncoupling in response to oxidative stress as part of the nat-
ural antioxidant defence system;10,12 although this remains
controversial.13Inactive
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Scheme 1. Proposed mode of action of caged uncouplers.
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OArylboronate esters react with hydrogen peroxide in mildly al-
kaline media to give phenols (e.g., at pH 8.3, which is the approx-
imate pH of the matrix of active mitochondria), and this has been
used to make a range of ﬂuorescent sensors that are sensitive to,
and selective for, hydrogen peroxide.5,14,15 One mode of action in-
volves the conversion of an arylboronate into a phenol, which
fragments to release a ﬂuorescent molecule.15 We aimed to use this
reaction to release the most commonly employed mitochondrial
uncouplers, dinitrophenol (DNP)11,16,17 1 and carbonylcyanide
p-triﬂuoromethoxyphenylhydrazone (FCCP) 2 (Fig. 1).11,18,19 These
are mildly acidic compounds (pKa 4.1
20 and 5.8,21 respectively) that
are deprotonated in the mitochondrial matrix to form lipophilic
anions DNP 3 and FCCP 4, which can cross the inner mitochon-
drial membrane, pick up a proton, and return. Thus, arylboronate 5,
bearing a caged uncoupler, should react with the hydroperoxide ion
in the alkaline medium of the mitochondrial matrix to give a borate
ester intermediate 6. Hydrolysis to give the phenoxide ion 7would
then be followed by fragmentation to give the active uncoupler 8
and the quinone methide side product 9, which would be trapped
rapidly by hydroxide or water to give 4-hydroxybenzyl alcohol 10
(Scheme 2).22NH
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Figure 1. Uncouplers in their protonated and unprotonated forms.Our ﬁrst targets, caged uncouplers 15 and 19 were synthesized
as shown (Scheme 3). 4-Bromobenzylic alcohol 11was protected as
the THF acetal 12. Lithiation–boronation gave arylboronate 13. This
was deprotected to give alcohol 14, which was used to displace
ﬂuoride from 2,4-dinitro-1-ﬂuorobenzene to yield caged un-
coupler 15. Alcohol 14 was converted into the bromide 16 by the
literature method,23 reaction with deprotonated malononitrile
gave arylboronate 17. This was then coupled with diazonium salt
18, freshly generated from 4-triﬂuoromethoxyaniline, to give caged
uncoupler 19.
The reaction between the caged uncouplers 15 and 19 and al-
kaline hydrogen peroxide was studied under pseudo-ﬁrst order
conditions. One millilitre of a 200 mM solution of the caged un-
coupler 15 in a 1:1 mixture of DMF and 0.14 M aqueous sodium
bicarbonate (pH 8.3) was treated at 37 C with 20 mM aqueous
hydrogen peroxide and the absorption monitored at 410 nm (theabsorption maximum of DNP 3 under these conditions). The av-
erage of three runs is presented in Figure 2. This gave a DAlim of
0.220 (0.006), corresponding to 10.7 mM DNP 3 released or
a yield of 54% relative to the hydrogen peroxide added. The average
apparent ﬁrst order rate constant was 1.85103 s1, giving a sec-
ond order rate constant kDNP of 9.3 M
1 s1. Repeating the experi-
ment with 10 mM hydrogen peroxide gave a DAlim of 0.122 (0.01),
corresponding to 5.96 mMDNP 3 released or a yield of 60% relative
to the hydrogen peroxide added. The average apparent ﬁrst order
rate constant was 2.16103 s1, giving a second order rate con-
stant kDNP of 10.8 M
1 s1. The overall value for kDNP is therefore 10
(0.8) M1 s1 and a 57 (3)% yield of DNP 3 was obtained withO
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Scheme 2. Reaction between caged uncouplers and hydrogen peroxide.
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Scheme 3. Synthesis of caged uncouplers 15 and 19.
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drogen peroxide to caged uncoupler 15 is clearly greater than 1:1. A
plausible explanation for this is that the para-quinone methide
produced by fragmentation of the probe is predominantly trapped
by hydrogen peroxide rather than water.
Similar experiments with caged uncoupler 19 gave good pseudo-
ﬁrst order kinetics, a calculated second order rate constant kFCCP of
64.8 (0.6) M1 s1 at pH 8.3 and a 58 (2)% yield of FCCP 4 rel-
ative to the hydrogen peroxide used. For comparison, the second
order rate constant for reaction between glutathione and hydrogen
peroxide at 37 C is only 0.87 M1 s1, albeit at pH 7.4. Thus, we
have demonstrated that caged uncouplers 15 and 19 react with
alkaline hydrogen peroxide to release uncouplers at a biologically
appropriate rate.
In summary, we have prepared the ﬁrst examples of hydrogen
peroxide-activated caged uncouplers and demonstrated that theyrelease the two most common uncoupling agents, DNP 3 and
FCCP 4, at a useful rate. The next stage will be to target these caged
uncouplers to mitochondria and test the mitochondrial free radical
theory of ageing.
2. Experimental
2.1. Synthesis
All reactions under an inert atmosphere were carried out using
oven dried or ﬂame-dried glassware. Solutions were added via
syringe. Tetrahydrofuran and dichloromethane were dried where
necessary using a solvent drying system, Puresolv, in which sol-
vent is pushed from its storage container under low nitrogen
pressure through two stainless steel columns containing activated
alumina and copper. Acetone was dried over 4 Å molecular sieves.
Triethylamine was dried by distillation over calcium hydride and
stored over potassium hydroxide. Reagents, including DNP 1, were
obtained from commercial suppliers and used without further
puriﬁcation unless otherwise stated. 1H, 13C and 19F NMR spectra
were obtained on a Bruker DPX/400 spectrometer operating at 400,
100 and 376 MHz, respectively. All coupling constants are mea-
sured in hertz. DEPT was used to assign the signals in the 13C NMR
spectra as C, CH, CH2 or CH3. Mass spectra (MS) were recorded on
a Jeol JMS700 (MStation) spectrometer. Infrared (IR) spectra were
obtained on a Shimadzu FTIR-8400S spectrometer using attenuated
total reﬂectance (ATR) so that the IR spectrum of the compound
(solid or liquid) could be directly detected (thin layer) without any
sample preparation.
2.2. Carbonyl cyanide 4-(triﬂuoromethoxy)phenylhydrazone
(FCCP) 2
A solution of NaNO2 (350 mg, 5.0 mmol) in water (5 mL) was
cooled to 0 C. This solution was added dropwise to a stirred so-
lution of 4-triﬂuoromethoxyaniline (886 mg, 5.0 mmol) in aqueous
hydrochloric acid (1.6 M, 35 mL) at 0 C. The mixture was stirred at
0 C for 5 min and then added dropwise into a stirred solution of
malononitrile (0.48 mL, 7.5 mmol) and NaOAc (12.5 g, 152 mmol) in
water (50 mL). A yellow precipitate formed was collected by ﬁl-
tration and was washed with ice-cold water. The precipitate was
dissolved in Et2O, dried overMgSO4 and the solvent removed under
reduced pressure. Recrystallization from EtOAc/hexane gave FCCP 2
as a yellow amorphous solid (951 mg, 75%). Mp 145–148 C
(decomp.). nmax (ATR): 3066 (CH), 2226 (CN), 1618 (Ar) cm
1. dH
(CDCl3, 400 MHz): 7.53 (2H, d, J¼9.2 Hz, H-2 and H-6), 7.20 (2H, m,
H-3 and H-5). dC (CDCl3, 100 MHz): 147.89 (C), 141.66 (C), 123.48
(CH), 121.91 (CF3, q, J¼254.1 Hz), 118.75 (CH), 114.47 (C), 109.85 (C),
87.57 (C). 1H and 13C NMR in good agreement with literature.24
2.3. 2-(40-Bromobenzyloxy)tetrahydrofuran 12
A solution of 4-bromobenzyl alcohol 11 (13.00 g, 69.5 mmol),
2,3-dihydrofuran (6.3 mL, 83.5 mmol) and para-toluene sulfonic
acid monohydrate (20 mg, 0.1 mmol) in anhydrous DCM (50 mL)
was stirred at rt for 1.5 h. The reaction mixture was then washed
with H2O (2100 mL) and saturated aqueous NaHCO3 (100 mL) and
the organic phase dried over MgSO4 and concentrated under re-
duced pressure to afford the acetal 12 as a yellow oil (17.17 g, 96%).
nmax (ATR): 2982 (CH), 2951 (CH), 2882 (CH), 1487 (Ar) cm
1. dH
(CDCl3, 400 MHz): 7.45 (2H, d, J¼8.3 Hz, H-30 and H-50), 7.20 (2H, d,
J¼8.3 Hz, H-20 and H-60), 5.19 (1H, dd, J¼2.6 and 3.7 Hz, H-2), 4.65
(1H, d, J¼12.4 Hz, ArCHAHB), 4.42 (1H, d, J¼12.4 Hz, ArCHAHB),
3.95–3.84 (2H, m, 2H-5), 2.07–1.80 (4H, m, 2H-3 and 2H-4). dC
(CDCl3, 100 MHz): 137.44 (C), 131.41 (CH), 129.43 (CH), 121.29 (C),
103.17 (CH), 67.97 (CH2), 67.08 (CH2), 32.34 (CH2), 23.44 (CH2).
Figure 2. Hydrogen peroxide triggered release of DNP/DNP from a 200 mM solution of caged uncoupler 15 in 1:1 DMF/aqueous NaHCO3 monitored by absorbance at 410 nm. Initial
concentrations of hydrogen peroxide were 20 mM for line (A) and 10 mM for line (B).
C. Quin et al. / Tetrahedron 66 (2010) 2384–2389 2387LRMS (EIþ): 258 [Mþ, (81Br), 13%], 256 [Mþ, (79Br), 13], 171
(81BrC6H4CH2
þ, 100), 169 (79BrC6H4CH2þ, 100), 71 (C4H7Oþ, 100).
HRMS: 258.0079 and 256.0099. C11H13
81BrO2 requires M
þ,
258.0085 and C11H13
79BrO2 requires M
þ, 256.0097.
2.4. 2-[40-(400,400,500,500-Tetramethyl-100,300,200-dioxaborolan-200-yl)-
benzyloxy]tetrahydrofuran 13
A solution of bromide 12 (12.00 g, 46.7 mmol) in anhydrous THF
(130 mL) was cooled to78 C and degassed with argon for 15 min.
Under argon, nBuLi (1.68 M in hexanes, 31.7 mL, 56.0 mmol) was
added dropwise over 3 h and themixture allowed to stir for 15 min.
2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (11.4 mL,
56.0 mmol) was added dropwise and the resulting solution allowed
to stir for 2 h. The reaction was quenched with H2O (100 mL) and
the product extracted with DCM (3100 mL). The organic layers
were combined, washed with brine (100 mL), dried over MgSO4
and concentrated under reduced pressure to give a yellow oil. Im-
purities were removed by Kugelrohr distillation leaving acetal 13 as
the residual yellow oil, which solidiﬁed on standing (11.87 g, 84%).
Mp: 41–44 C. nmax (ATR): 2978 (CH), 2932 (CH), 2882 (CH), 1614
(Ar) cm1. dH (CDCl3, 400 MHz): 7.78 (2H, d, J¼7.7 Hz, H-30 and H-
50), 7.34 (2H, d, J¼7.7 Hz, H-40 and H-60), 5.20 (1H, dd, J¼1.2 and
4.2 Hz, H-20), 4.72 (1H, d, J¼12.4 Hz, ArCHAHB), 4.50 (1H, d,
J¼12.4 Hz, ArCHAHB), 3.97–3.86 (2H, m, 2H-5), 2.09–1.83 (4H, m,
2H-3 and 2H-4), 1.34 (12H, s, 4Me). dC (CDCl3, 100 MHz):
141.60 (C), 134.86 (CH), 126.99 (CH), 103.09 (CH), 83.73 (C), 68.60
(CH2), 67.02 (CH2), 32.33 (CH2), 24.84 (CH3), 23.44 (CH2). LRMS
(EIþ): 304 (Mþ, 4%), 217 (75), 83 (100). HRMS: 304.1842.
C17H25
11BO4 requires M
þ, 304.1846.
2.5. [4-(40,40,50,50-Tetramethyl-10,30,20-dioxaborolan-20-yl)-
phenyl]methanol 14
Aluminium trichloride (40 mg, 0.30 mmol) was added to a stir-
red solution of acetal 13 (1.00 g, 3.29 mmol) in anhydrous EtOH
(10 mL). The mixture was stirred overnight at rt and then concen-
trated under reduced pressure. The mixture was dissolved in Et2O
and undissolved solid was removed by ﬁltration. The ﬁltrate was
evaporated under reduced pressure and redissolved in anhydrous
EtOH (10 mL). Aluminium trichloride (30 mg, 0.22 mmol) was
added and the solutionwas stirred overnight at rt. The mixture was
concentrated under reduced pressure, dissolved in Et2O and ﬁltered
to remove undissolved solid. The solution was then concentrated
under reduced pressure to afford the benzylic alcohol 14 as an oil(517 mg, 67%). nmax (ATR): 3312 (OH), 2978 (CH), 2930 (CH), 2880
(CH), 1614 (Ar) cm1. dH (CDCl3, 400 MHz): 7.78 (2H, d, J¼7.6 Hz, H-
3 and H-50), 7.33 (2H, d, J¼7.7 Hz, H-2 and H-6), 4.66 (2H, s, ArCH2),
1.33 (12H, s, 4Me). dC (CDCl3, 100 MHz): 144.07 (C), 134.99 (CH),
126.06 (CH), 83.82 (C), 65.05 (CH2), 24.83 (CH3). LRMS (EI
þ): 234
[Mþ, 50%], 135 [HOCH2C6H411BOHþ, 100]. HRMS: 234.1426.
C13H19
11BO3 requires M
þ, 234.1427. 1H and 13C NMR agree with
literature.23
2.6. 2-[40-(200,400-Dinitrophenoxymethyl)phenyl]-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane 15
Benzylic alcohol 14 (200 mg, 0.854 mmol) was mixed with 2,4-
dinitroﬂuorobenzene (0.11 mL, 4.1 mmol) and two drops of anhy-
drous triethylamine added. The reaction mixture was stirred at rt
overnight and then concentrated under reduced pressure. The
mixture was triturated with ether and the resulting pale yellow
solid recrystallized from EtOAc/hexane to afford caged uncoupler
15 as an amorphous solid (72 mg, 21%). Rf [SiO2, petroleum ether/
EtOAc (4:1)]: 0.23. Mp: 143–145 C. nmax (ATR): 2981 (CH), 2931
(CH), 2894 (CH), 1604 (Ar), 1521 (NO2), 1342 (NO2) cm
1. dH (CDCl3,
400 MHz): 8.74 (1H, d, J¼2.8 Hz, H-300), 8.34 (1H, dd, J¼2.8 and
9.3 Hz, H-500), 7.85 (2H, d, J¼8.1 Hz, H-20 and H-60), 7.44 (2H, d,
J¼8.1 Hz, H-30 and H-60), 7.21 (1H, d, J¼9.3 Hz, H-600), 5.39 (2H, s,
ArCH2), 1.35 (12H, s, 4Me). dC (CDCl3, 100 MHz): 156.21 (C), 140.23
(C), 139.24 (C), 136.90 (C), 135.39 (CH), 128.95 (CH), 126.15 (CH),
121.96 (CH), 114.98 (CH), 84.01 (C), 71.98 (CH2), 24.86 (CH3). LRMS
(CIþ): 401 [(MþH)þ, 50%], 219 (100). HRMS: 401.1521.
C19H22
11BN2O7 requires (MþH)þ, 401.1520.
2.7. 2-(40-Bromomethylphenyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane 16
Following the procedure of De Filippis et al.,23 benzylic alcohol
14 (500 mg, 2.14 mmol) was dissolved in anhydrous DCM (15 mL)
and degassed with argon for 15 min. The solution was cooled to
0 C and anhydrous triethylamine (324 mg, 3.20 mmol) was added.
Methanesulfonyl chloride (198 mL, 2.56 mmol) was added and the
solution was allowed to stir for 1 h. Organics were washed with
H2O (34 mL), dried over MgSO4 and concentrated under reduced
pressure. The resultant solid was dissolved in anhydrous acetone
(15 mL) and degassed with argon for 15 min. Lithium bromide
(1.90 g, 21.4 mmol) was added and the resultant solution was
heated under reﬂux overnight. The solution was concentrated un-
der reduced pressure and the residue dissolved in DCM (15 mL),
C. Quin et al. / Tetrahedron 66 (2010) 2384–23892388washed with H2O (34 mL), dried over MgSO4 and concentrated
under reduced pressure to yield the target bromide 16 as an
amorphous solid (413 mg, 63%). Mp: 76–78 C (cubes from Et2O/
hexane. Lit.23 75–77 C). nmax (ATR): 2976 (CH), 2930 (CH), 2872
(CH), 1613 (Ar) cm1. dH (400 MHz, CDCl3): 7.79 (2H, d, J¼7.7 Hz, H-
20 and H-60), 7.39 (2H, d, J¼7.7 Hz, H-30 and H-50), 4.49 (2H, s, CH2),
1.34 (12H, s, 4Me). dC (100 MHz, CDCl3): 140.65 (C), 135.21 (CH),
128.30 (CH), 83.90 (C), 33.33 (CH2), 24.84 (CH3). LRMS (EI
þ): 298
[Mþ, (81Br), 4%], 296 [Mþ, (79Br), 4], 217 [MþBr, 100]. HRMS:
298.0549 and 296.0567. C13H18
11B81BrO2 requires M
þ, 298.0563
and C13H18
11B79BrO2 requires M
þ, 296.0583. 13C NMR agrees with
literature.23
2.8. 2-Cyano-2-[40-(400,400,500,500-tetramethyl-1,3,2-
dioxaborolan-2-yl)phenyl]propionitrile 17
A suspension of NaH (80% in mineral oil, 70 mg, 2.3 mmol) in
anhydrous THF (16 mL) and anhydrous DMF (1.6 mL) was stirred
at rt under argon. A solution of malononitrile (0.12 mL, 2.3 mmol)
in anhydrous THF (2 mL) was added dropwise to the solution and
hydrogen gas was evolved. The reaction mixture was stirred at rt
for 30 min under argon before a solution of bromide 16 (329 mg,
1.11 mmol) in anhydrous THF (4 mL) was added dropwise. The
reaction mixture was stirred at 25 C overnight. Saturated aque-
ous NH4Cl (40 mL) was added to quench the reaction and the
mixture was extracted with EtOAc (320 mL). The combined or-
ganic extracts were washed with H2O (320 mL), dried over
MgSO4 and concentrated under reduced pressure. Column chro-
matography [SiO2, hexane/EtOAc (4:1)] then gave the product
boronate ester 17 as an amorphous solid (281 mg, 90%). Rf [SiO2,
hexane/EtOAc (4:1)]: 0.13. Mp: 135–137 C. nmax (ATR): 2982 (CH),
2361 (CN), 1614 (Ar) cm1. dH (400 MHz, CDCl3): 7.84 (2H, d,
J¼7.1 Hz, H-2 and H-6), 7.32 (2H, d, J¼7.2 Hz, H-3 and H-5), 3.94
[1H, t, J¼6.8 Hz, CH(CN)2], 3.26 (2H, d, J¼6.8 Hz, CH2), 1.34 (12H, s,
4CH3). dC (100 MHz, CDCl3): 135.86 (C), 135.61 (CH), 128.46 (CH),
112.19 (C), 84.00 (C), 77.30 (CH), 36.66 (CH2), 24.85 (CH3). LRMS
(CIþ): 283 [(MþH)þ, 100%]. HRMS: 283.1613. C16H20O2N211B re-
quires (MþH)þ, 283.1621.
2.9. 2-Cyano-3-[40-(400,400,500,500-tetramethyl-100,300,200-
dioxaborolan-200-yl)phenyl]-2-(4%-triﬂuoro-
methoxyphenyldiazo)propionitrile 19
A solution of NaNO2 (25 mg, 0.36 mmol) in H2O (0.3 mL) was
cooled to 0 C and added dropwise to a stirred solution of 4-tri-
ﬂuoromethoxyaniline (62.8 mg, 0.355 mmol) and concd HCl
(0.2 mL) in H2O (1.5 mL) at 0 C. The resulting solution of di-
azonium salt 18was stirred for 5 min and then added dropwise to
a stirred solution of boronate 17 (100 mg, 0.354 mmol) and NaOAc
(116 mg, 1.42 mmol), in a mixture of H2O (1.3 mL), MeOH (1.5 mL)
and EtOH (1.5 mL) at 0 C. The resultant solution was stirred at
0 C for 1 h and then at rt overnight. The precipitate was ﬁltered
off and washed with ice-cold H2O (4 mL) to yield the caged un-
coupler 19 as an amorphous yellow solid. Further material was
obtained by concentration of the ﬁltrate under reduced pressure
followed by extraction with DCM. Removal of solvent under re-
duced pressure followed by chromatography [SiO2, petroleum
ether/EtOAc (9:1)] gave further caged uncoupler 19 (combined
yield 77 mg, 46%). Rf [SiO2, petroleum ether/EtOAc (9:1)]: 0.34.
Mp: 120–122 C. nmax (ATR): 2937 (CH), 2162 (CN), 1614 (Ar) cm1.
dH (CDCl3, 400 MHz): 7.90 (2H, d, J¼9.0 Hz, H-2% and H-6%), 7.82
(2H, d, J¼8.0 Hz, H-30 and H-50), 7.36–7.39 (4H, m, H-20, H-60, H-3%
and H-5%), 3.69 (2H, s, CH2), 1.34 (12H, s, 4CH3). dC (CDCl3,
100 MHz): 153.08 (C), 147.71 (C), 135.51 (CH), 132.86 (C), 130.15
(CH), 125.81 (CH), 121.48 (CH), 120.38 (q, J¼259.2 Hz), 111.85 (C),
84.17 (C), 69.35 (C), 36.62 (CH2), 24.99 (CH3). dF (CDCl3, 376 MHz):57.58. LRMS (CIþ): 471 [(MþH)þ, 11B, 11%], 446 (39), 337 (40), 283
(95), 219 (91), 189 (100). HRMS: 471.1821. C23H23O3N4F3
11B re-
quires (MþH)þ, 471.1820.
2.10. Details of kinetic experiments
The stock solutions of caged uncouplers were made up by
weight in DMF (caged uncoupler 15, 1 mM; caged uncoupler 19,
10 mM). The concentration of the stock H2O2 solution was checked
by titration against KMnO4,
25 and diluted accurately to a concen-
tration of 1 mM. Reactions were carried out in a 1:1 mixture of DMF
and 0.14 M aqueous sodium bicarbonate (pH 8.3).
Absorption measurements were made on a JASCO V550 double
beam spectrophotometer using matched quartz cuvettes of 1 cm
pathlength, with the cuvette compartment maintained at 37 C by
a circulating water bath. The spectrophotometer was calibrated
using a solution of potassium chromate in 0.05 M KOH, whose
absorption coefﬁcient at 372 nm is 4830 M1 cm1.26 For this
standard solution, the measured absorbance was proportional to
concentration up to an absorbance of 1.2; all measurements
reported in this paper were made with absorbance values less
than 1.0.
Comparison between the spectra of caged uncoupler 15 and
DNP 3, and between caged uncoupler 19 and FCCP 4 showed
that the appropriate wavelengths to monitor the reactions were
410 nm and 385 nm, respectively, since in each case the starting
material showed a very much smaller absorption than the
product. The appropriate absorption coefﬁcients for the prod-
ucts (DNP 3 at 410 nm and FCCP 4 at 385 nm) under the
conditions used for the reactions were determined using a par-
allel dilution approach in which stock solutions of these com-
pounds were diluted into buffer systems where the absorption
coefﬁcients had been published,27,28 and into the buffer system
used in the present work. Comparison of the observed absor-
bance values from these parallel dilutions allowed the appro-
priate coefﬁcients for our experiments to be calculated
(20,500 M1 cm1 at 410 nm for DNP 3 and 29,700 M1 cm1 at
385 nm for FCCP 4).
Reactions were initiated by adding small aliquots of H2O2 to
solutions of caged uncoupler 15 or caged uncoupler 19 in the DMF/
buffer mixture, in a total volume of 1 mL. The blank reaction con-
tained DMF/buffer in place of the H2O2. Control experiments
showed that, under the conditions used, there was a slow break-
down of the caged uncouplers in the buffer; in the case of caged
uncoupler 15, this amounted to 3% of the initial compound over
a time period of 2000 s; in the case of caged uncoupler 19, this
amounted to 14% of the initial compound over a time period of
1000 s. Since the reactions were carried out with the caged un-
couplers in considerable excess over H2O2 and the uncouplers in
DMF/buffer solution were used in the blank reaction, the sponta-
neous breakdown did not affect the observed pseudo-ﬁrst order
rate constants for the production of DNP 3 or FCCP 4 or the
observed yields, although it would have small effects on the cal-
culated second order rate constants. The concentrations of the
caged uncouplers and H2O2 were chosen to give convenient rates of
reaction while maintaining a reasonable approximation to pseudo-
ﬁrst order conditions in order to facilitate kinetic analysis. For caged
uncoupler 15, the concentration used was 200 mM and the H2O2
concentrations 10 mM and 20 mM. Reactions were performed in
triplicate. For caged uncoupler 19, the concentration used was
50 mM, and the H2O2 concentrations 5 mM and 10 mM. Reactions
were performed in triplicate at 5 mM H2O2, and in duplicate at
10 mM H2O2. In each case, the experimental data (absorbance vs
time) were ﬁtted to a ﬁrst order kinetic process using Microcal
Origin software; this gave the end-point (limiting absorbance
change) and the ﬁrst order rate constant. Division of this rate
C. Quin et al. / Tetrahedron 66 (2010) 2384–2389 2389constant by the concentration of the caged uncoupler in excess
yielded the second order rate constant for the reaction.
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